Modern problems of treatment of Helicobacter-associated diseases in children: opportunities of adjuvant therapy

Journal Title: Здоров`я дитини - Year 2017, Vol 12, Issue 2

Abstract

Background. The relevance of research is related to a significant spread of the pathology of the upper digestive tract in children, which in most cases is caused by the pathogenic effect of Helicobacter pylori (Hp). Modern eradication strategies require adjuvant therapy. The aim of the study was to evaluate the clinical effectiveness of the Lactiale symbiotic as an adjuvant therapy for eradication schemes in children of different ages with the pathology of the upper digestive canal. Materials and methods. Seventy children with Hp-associated pathology of the upper digestive tract aged 5 to 18 years were under observation. Patients were divided into 2 groups depending on the use of the symbiotic. The diagnosis was verified using fibrogastroscopy, endoscopic pH-metry, determination of Hp-infection, morphological examination. The results were statistically processed. Results. The results of using Lactiale symbiotic in patients of group 1 as an adjuvant therapy for standard pediatric Hp eradication schemes suggest the expediency and high effectiveness of such treatment. The dyna- mics of complaints, absence of side effects and good tolerabi-lity of drugs against the background of reception of a symbiotic were positive. The increase in eradication efficiency by 10 % compared with standard schemes corresponds to the results of other studies. The positive influence of the symbiotic on the processes of qualitative healing of ulcers and a significant increase in anti-inflammatory effect in patients of the main subgroup with peptic ulcer of the duodenum was determined. The low result of eradication, obtained in patients with functional disorders, can be considered predictable. This is evidenced by the latest conciliatory conclusions of experts: the effectiveness of eradication in patients with functional dyspepsia does not exceed 15–30 %. Conclusions. The use of the Lactiale symbio-tic as an adjuvant therapy for eradication schemes in children of different ages with Hp-associated pathology of the upper digestive tract is advisable, significantly increases the effectiveness of eradication, improves the tolerability of drugs, adhe-rence of patients to the treatment.

Authors and Affiliations

O. Yu. Belousova, N. V. Pavlenko, K. V. Voloshin, O. B. Hanzii, O. L. Slobodianiuk

Keywords

Related Articles

Features of Microcirculatory Disoders in Gastric Mucosa and Duodenal Mucosa in Children with Chronic Gastroduodenitis

The article displays the main histological and immunohistochemical features of microcirculatory disorders in gastric mucosa and duodenal mucosa. The obtained data provide a differentiated approach to the prescription of...

Social and Biological Risk Factors for the Development of Physical Abnormalities in Infants with Perinatal Lesions of the Central Nervous System

We observed 448 children aged 1 to 3 years with perinatal lesions of the central nervous system (CNS) of hypoxic-ischemic origin and mild to moderate severity. The objective of research — identification of social and bio...

Interferon therapy of acute respiratory viral infections in children

The purpose of our study was to evaluate the efficacy and tolerability of nasal spray Laferobionum® (100,000 IU/ml) in children with acute respiratory viral infections. Materials and methods. The study included 84 child...

Role of Аntenatal Antigen Impact on Cardiovascular System Morphogenesis

In this paper we consider the state of the cardiovascular system in infants with congenital toxoplasmosis without congenital heart disease, carditis (as a model of antenatal antigenic exposure) and features of morphogene...

Features of Diagnosing and Managing a Patient with DiGeorge Syndrome

The article presents a case of own clinical observation of DiGeorge syndrome (22q11.2 chromosome deletion syndrome) in a child. The features of the disease course with the dominance of clinical symptoms of congenital mal...

Download PDF file
  • EP ID EP184105
  • DOI 10.22141/2224-0551.12.2.1.2017.100987
  • Views 64
  • Downloads 0

How To Cite

O. Yu. Belousova, N. V. Pavlenko, K. V. Voloshin, O. B. Hanzii, O. L. Slobodianiuk (2017). Modern problems of treatment of Helicobacter-associated diseases in children: opportunities of adjuvant therapy. Здоров`я дитини, 12(2), 239-248. https://europub.co.uk/articles/-A-184105